S100A9 抗体(YA3464) (HY-P83734)
Leukocyte L1 complex heavy chain antibody; 60B8AG antibody; CAGB antibody; Calgranulin B antibody; Calgranulin-B antibody; Calprotectin L1H subunit antibody; CFAG antibody; CGLB antibody; Cystic fibrosis antigen B antibody; L1AG antibody; Leukocyte L1 complex heavy chain antibody; LIAG antibody; MAC387 antibody; MIF antibody; Migration inhibitory factor related protein 14 antibody; Migration inhibitory factor-related protein 14 antibody; MRP 14 antibody; MRP-14 antibody; MRP14 antibody; Myeloid-
用户验证的应用
经验证应用
| 项目 | 详情 |
|---|---|
| IHC-P | Immunohistochemical analysis of paraffin-embedded human lung cancer tissue using S100A9 Antibody (HY-P83734, 1/5000). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. Immunohistochemical analysis of paraffin-embedded human breast cancer tissue using S100A9 Antibody (HY-P83734, 1/5000). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using S100A9 Antibody (HY-P83734, 1/5000). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. Immunohistochemical analysis of paraffin-embedded human endometrial cancer tissue using S100A9 Antibody (HY-P83734, 1/5000). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. Immunohistochemical analysis of paraffin-embedded human skin cancer tissue using S100A9 Antibody (HY-P83734, 1/5000). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. Immunohistochemical analysis of paraffin-embedded human stomach cancer tissue using S100A9 Antibody (HY-P83734, 1/5000). The section was pretreated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked with quick block buffer for 0.5 hours at room temperature, washed with PBS and PBST, and then incubated with the primary antibody overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. |
详细信息
背景信息
功能: S100A9 是一种钙结合 S100 家族蛋白,主要由中性粒细胞和单核细胞释放,它通常与 S100A8 形成 S100A8/A9 钙卫蛋白异二聚体,参与先天免疫炎症反应 [1] 。机制上,胞外 S100A9 与 TLR4 结合,CD14 作为辅助受体,诱导单核细胞中 NF-κB 激活和促炎细胞因子反应 [2] 。S100A8/A9 复合物还通过 TLR4、RAGE、NF-κB 和 MAPK 通路激活炎症信号通路,从而将白细胞募集、细胞因子分泌、感染防御和炎症相关疾病模型联系起来 [1] [3] 。在肿瘤模型中,S100A9-TLR4 信号通路促进肿瘤生长,而 S100A9 缺陷、TLR4 缺陷或 ABR-215050/tasquinimod 联合治疗则抑制 EL4 淋巴瘤的生长 [4] 。与相关亚型相比,S100A9 与 S100A8 和 S100A12 的不同之处在于,其最显著的炎症作用通常依赖于与 S100A8 的异二聚化以及受体特异性 TLR4/CD14 信号通路 [1] [2] [3] 。在实验应用中,paquinimod 可降低胶原酶诱导的高滑膜激活型骨关节炎中的滑膜激活、骨赘形成和软骨损伤 [5] 。 亚细胞定位: 分泌的;细胞质;细胞质、细胞骨架;细胞膜;外周膜蛋白 表达水平: 组织特异性:钙卫蛋白 (S100A8/9) 主要在髓系细胞中表达。除炎症状态外,其表达仅限于髓系分化的特定阶段,因为这两种蛋白均在循环中性粒细胞和单核细胞中表达,但在正常组织巨噬细胞和淋巴细胞中则不存在。在慢性炎症状态下,例如银屑病和恶性肿瘤,表皮中也会表达钙卫蛋白。在炎症局部部位或患有炎症性疾病 (例如类风湿性关节炎、囊性纤维化、炎症性肠病、克罗恩病、巨细胞动脉炎、干燥综合征、系统性红斑狼疮和进行性系统性硬化症) 的血清中,钙卫蛋白的浓度较高。钙卫蛋白参与衰老前列腺中淀粉样蛋白 (称为淀粉样小体包涵体) 的形成和沉积。在多种肿瘤中均有显著上调,包括胃癌、食管癌、结肠癌、胰腺癌、膀胱癌、卵巢癌、甲状腺癌、乳腺癌和皮肤癌。 阳性样本:Human cervical cancer, human breast cancer tissue, human spleen tissue. 亚基: 同源二聚体 (PubMed:11851337, PubMed:16258195)。优先以异源二聚体或异源四聚体的形式与 S100A8 结合,称为钙卫蛋白 (S100A8/A9)(PubMed:16258195, PubMed:17553524, PubMed:19087201, PubMed:19122197, PubMed:25417112, PubMed:8423249, PubMed:9083090)。